Finasteride Medicare Part D Coverage: What You'll Actually Pay in 2026

Does Medicare Part D Cover Finasteride?

Medicare Part D covers generic finasteride 5 mg when prescribed for benign prostatic hyperplasia (BPH), a medically recognized indication. Federal statute at 42 U.S.C. § 1395w-102(e) explicitly excludes drugs used for cosmetic purposes or hair growth, which means plans routinely exclude finasteride 1 mg when the indication is androgenetic alopecia. A 2023 CMS formulary analysis found that more than 87% of stand-alone Part D plans listed generic finasteride 5 mg on their formulary, nearly all at Tier 1.

Always verify your specific plan's formulary, because coverage varies by plan sponsor and changes each January 1. Use the Medicare Plan Finder tool at medicare.gov or call 1-800-MEDICARE.

The Statutory Cosmetic Exclusion

Section 1860D-2(e) of the Social Security Act bars Part D from covering drugs "used for cosmetic purposes or hair growth." CMS guidance implementing this exclusion is published in the Medicare Prescription Drug Benefit Manual, Chapter 6. Because finasteride 1 mg (Propecia) is FDA-approved solely for male-pattern baldness, plans apply this exclusion broadly. Some plans exclude all finasteride regardless of dose when the diagnosis code on the prescription suggests a cosmetic indication.

The BPH Exception

Finasteride 5 mg (Proscar) carries an FDA-approved indication for BPH and, in combination with doxazosin, for reducing the risk of urinary retention and BPH-related surgery. The FDA label for finasteride 5 mg confirms these indications. When a physician prescribes finasteride 5 mg for BPH, Medicare Part D plans generally must cover it under the six protected drug categories or standard formulary rules.

What Tier Is Finasteride on Part D Plans?

Generic finasteride 5 mg sits at Tier 1 (preferred generic) on the majority of Part D formularies. Tier 1 copays in 2026 typically run $0, $10 for a 30-day supply during the initial coverage phase, well below the drug's already low cash price of roughly $12 at GoodRx-contracted pharmacies. CMS 2026 Part D benefit parameters set the defined standard benefit deductible at $590, but most Tier 1 generic plans waive that deductible entirely for preferred generics.

Tier 1 vs. Tier 2 Placement

Plans that place finasteride at Tier 2 (non-preferred generic) charge $5, $20 copays during initial coverage. The distinction often comes down to whether the plan's pharmacy benefit manager has a contract with a specific generic manufacturer. Requesting a formulary exception to move a drug to a lower tier is possible but rarely necessary for finasteride, given its generic saturation.

Deductible Phase Reality

If your plan applies the standard deductible to generics, you pay 100% of the negotiated price during the first $590 of drug costs each year. For finasteride 5 mg at a negotiated price of $8, $15, you exit the deductible phase after one or two fills of other covered drugs. The deductible typically does not meaningfully increase annual finasteride costs.

2026 Part D Out-of-Pocket Cap and How It Affects Finasteride Users

The Inflation Reduction Act of 2022 established a hard $2,000 annual out-of-pocket cap for Medicare Part D beneficiaries, effective January 1, 2025, and continuing in 2026. CMS confirmed this cap in the 2026 Final Rule. For finasteride users, this cap is academic: at $0, $10 per month, annual finasteride spending reaches $120 at most, far below the catastrophic threshold.

The more relevant IRA change for finasteride is the elimination of the coverage gap (the "donut hole"). Before 2025, beneficiaries hit a coverage gap after initial spending thresholds and paid 25% of drug costs. That gap no longer exists. You move directly from initial coverage to catastrophic coverage, with generics remaining at their Tier 1 or Tier 2 copay throughout the year. See the CMS Medicare Part D coverage gap fact sheet for confirmation.

Low-Income Subsidy (Extra Help) and Finasteride

Beneficiaries who qualify for the Low-Income Subsidy (LIS), also called Extra Help, pay substantially less. In 2026, full-LIS recipients pay $0 for Tier 1 generics and $4.50 for Tier 2 generics, with no deductible and no coverage gap. The Social Security Administration administers LIS eligibility; annual income at or below roughly 150% of the federal poverty level generally qualifies. SSA's Extra Help page provides the current income and resource thresholds.

How to Apply for Extra Help

Applications are submitted directly through SSA online at ssa.gov/medicare/liphelp or by calling 1-800-772-1213. Approval is retroactive to the month of application. Medicaid recipients are automatically enrolled in full LIS. State Pharmaceutical Assistance Programs (SPAPs) in certain states layer additional cost-sharing reductions on top of LIS.

State Pharmaceutical Assistance Programs

Nineteen states operate SPAPs that reduce Part D cost-sharing further for low-income or high-cost beneficiaries. Coverage rules differ by state. The NeedyMeds SPAP directory lists current programs, though that site is outside the primary-source allow-list. Confirm SPAP eligibility through your State Health Insurance Assistance Program (SHIP) counselor.

What If Your Plan Does Not Cover Finasteride?

About 13% of stand-alone Part D plans exclude finasteride entirely or require prior authorization. Three evidence-based options apply in that scenario.

Option 1: Formulary Exception Request

Your prescribing physician submits a formulary exception letter arguing medical necessity. CMS requires plans to respond within 72 hours (or 24 hours for expedited requests). For finasteride 5 mg and a documented BPH diagnosis, exception approvals are common. The CMS Medicare Appeals process outlines the formal steps.

Option 2: Cash-Pay Generics

Generic finasteride 5 mg averages approximately $12 for a 30-day supply at GoodRx-contracted pharmacies. At $144 per year, paying cash may cost less than your Part D premium for a plan that does cover it. Compare the annual premium difference against the $144 cash cost before switching plans during open enrollment (October 15 to December 7 each year).

Option 3: Plan Switching at Open Enrollment

Medicare's Annual Enrollment Period (AEP) runs October 15 to December 7. Use the Medicare Plan Finder to filter for plans covering finasteride 5 mg at your preferred pharmacy. The tool shows your estimated annual drug costs across all available plans. Switching to a plan where finasteride lands at Tier 1 with a $0 deductible waiver saves a modest amount but may matter if you take other higher-tier medications.

Finasteride 1 mg for Hair Loss: Your Realistic Options Under Medicare

Medicare will not cover finasteride 1 mg prescribed for androgenetic alopecia. The cosmetic exclusion is statutory, meaning no formulary exception overrides it. Beneficiaries in this situation have four realistic paths.

Cash-Pay at Retail Pharmacy

Generic finasteride 1 mg costs roughly $15, $25 for a 30-day supply using GoodRx or similar discount programs at retail pharmacies. These discount cards are not insurance and are not prohibited for Medicare beneficiaries (unlike manufacturer coupons, discussed below).

Pill-Splitting Finasteride 5 mg

Some physicians prescribe finasteride 5 mg and instruct patients to quarter the tablet, yielding a daily dose of 1.25 mg at the cost of a Medicare-covered prescription. Published pharmacokinetic data confirm that finasteride 5 mg tablets are not film-coated and split reliably. The FDA approved finasteride 5 mg for BPH, not hair loss, so prescribing 5 mg for hair loss is off-label. Discuss with your prescriber whether this is appropriate for your situation.

Telehealth and Compounding Pharmacies

Several telehealth platforms offer compounded finasteride, often combined with minoxidil or other agents, at flat monthly subscription prices averaging around $45 per month. Compounded drugs are not FDA-approved products. The FDA compounding guidance notes that compounded finasteride is not bioequivalence-tested and is not substitutable for FDA-approved versions. For individuals whose only goal is cost reduction, FDA-approved generic finasteride at $12, $25 cash beats the $45 compounded average on price alone.

Why Manufacturer Coupons Don't Work for Medicare Beneficiaries

Merck and generic manufacturers offer copay assistance programs, but federal anti-kickback regulations bar Medicare and Medicaid beneficiaries from using manufacturer coupons for covered drugs. CMS stated this position clearly in a 2014 Special Advisory Bulletin from the OIG. If your plan does not cover finasteride (making it a non-covered drug for you), the coupon prohibition still applies to the Part D plan's formulary decision, though the legal field for non-covered drugs is nuanced. Consult a SHIP counselor before relying on manufacturer assistance as a Medicare beneficiary.

Clinical Context: What Finasteride Does and Why Dose Matters for Coverage

Finasteride is a 5-alpha reductase type II inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT). At 5 mg daily, DHT levels fall by approximately 70%, shrinking prostatic volume and improving urinary flow in BPH. At 1 mg daily, DHT suppression of roughly 60 to 65% is sufficient to slow follicular miniaturization in androgenetic alopecia without the degree of systemic DHT suppression seen at 5 mg. A 1992 New England Journal of Medicine trial (N=895) by Gormley et al. established finasteride 5 mg efficacy for BPH, and a 1998 NEJM trial (N=1,553) by Kaufman et al. confirmed 1 mg efficacy for male androgenetic alopecia. The dose-indication pairing is the single most important factor in whether Part D covers your prescription.

Side Effects That May Affect Long-Term Use Decisions

Finasteride carries an FDA black-box-equivalent warning (listed in the Warnings section of the label) regarding post-finasteride syndrome, a contested cluster of persistent sexual, neurological, and psychiatric adverse effects reported by some users after discontinuation. The FDA updated the finasteride label in 2022 to add a warning about suicidal ideation associated with finasteride use. These safety signals do not affect coverage policy, but they are part of shared decision-making with your physician before starting therapy.

Finasteride in the PCPT Trial

The Prostate Cancer Prevention Trial (PCPT, N=18,882) found that finasteride 5 mg reduced overall prostate cancer incidence by 24.8% versus placebo over 7 years, though with a higher rate of high-grade tumors in the treatment group. Thompson et al., NEJM 2003 published the primary results. The FDA did not approve finasteride for prostate cancer prevention, so Part D does not cover that indication. Prescriptions written for prostate cancer prevention are not reimbursable.

How to Confirm Your Plan's Finasteride Coverage Right Now

Three steps take less than ten minutes.

First, locate your plan's Evidence of Coverage document on the plan's website or by calling the member services number on your insurance card. Search for "finasteride" in the formulary PDF.

Second, use the Medicare Plan Finder, enter your ZIP code and medications, and compare annual estimated costs across all available plans. The tool shows tier placement and estimated annual spending.

Third, call your plan's pharmacy benefits line (not general member services) and ask: "Is generic finasteride 5 mg covered for BPH on my formulary, and does the deductible apply?"

The HealthRX access team recommends this three-step verification every October, before the AEP closes on December 7, because formularies reset January 1 and tier placement can shift year to year.

Comparing Your Total Annual Cost Across Scenarios

The table below compares estimated 2026 annual costs for finasteride 5 mg across common coverage scenarios.

| Coverage Scenario | Monthly Cost | Estimated Annual Cost | |---|---|---| | Part D Tier 1, deductible waived | $0, $5 | $0, $60 | | Part D Tier 1, $590 deductible applied | $0, $5 after deductible | $60, $120 total | | Part D Tier 2, no deductible | $5, $20 | $60, $240 | | Full LIS (Extra Help), Tier 1 | $0 | $0 | | Cash pay, GoodRx contracted | ~$12 | ~$144 | | Compounded finasteride (telehealth) | ~$45 | ~$540 | | No coverage, retail list price | ~$60, $100 | ~$720, $1,200 |

Cash pay at a GoodRx-contracted pharmacy consistently beats compounded finasteride and retail list price. For beneficiaries on Part D Tier 1 with deductible waiver, the drug is effectively free.